BLUEJAY DIAGNOSTICS INC (BJDX) Fundamental Analysis & Valuation

NASDAQ:BJDX • US0956336087

Current stock price

2 USD
+0.08 (+4.17%)
Last:

This BJDX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BJDX Profitability Analysis

1.1 Basic Checks

  • In the past year BJDX has reported negative net income.
  • BJDX had a negative operating cash flow in the past year.
  • BJDX had negative earnings in each of the past 5 years.
  • In the past 5 years BJDX always reported negative operating cash flow.
BJDX Yearly Net Income VS EBIT VS OCF VS FCFBJDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • BJDX's Return On Assets of -96.20% is on the low side compared to the rest of the industry. BJDX is outperformed by 81.28% of its industry peers.
  • BJDX's Return On Equity of -114.61% is on the low side compared to the rest of the industry. BJDX is outperformed by 66.84% of its industry peers.
Industry RankSector Rank
ROA -96.2%
ROE -114.61%
ROIC N/A
ROA(3y)-205.07%
ROA(5y)-140.12%
ROE(3y)-274.65%
ROE(5y)-184.33%
ROIC(3y)N/A
ROIC(5y)N/A
BJDX Yearly ROA, ROE, ROICBJDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BJDX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BJDX Yearly Profit, Operating, Gross MarginsBJDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BJDX Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BJDX has been increased compared to 1 year ago.
  • The number of shares outstanding for BJDX has been increased compared to 5 years ago.
  • Compared to 1 year ago, BJDX has an improved debt to assets ratio.
BJDX Yearly Shares OutstandingBJDX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50K 100K 150K
BJDX Yearly Total Debt VS Total AssetsBJDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • Based on the Altman-Z score of -9.62, we must say that BJDX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BJDX (-9.62) is worse than 80.21% of its industry peers.
  • BJDX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • BJDX's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. BJDX outperforms 73.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.62
ROIC/WACCN/A
WACCN/A
BJDX Yearly LT Debt VS Equity VS FCFBJDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • BJDX has a Current Ratio of 4.88. This indicates that BJDX is financially healthy and has no problem in meeting its short term obligations.
  • BJDX's Current ratio of 4.88 is fine compared to the rest of the industry. BJDX outperforms 74.33% of its industry peers.
  • BJDX has a Quick Ratio of 4.88. This indicates that BJDX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BJDX (4.88) is better than 79.14% of its industry peers.
Industry RankSector Rank
Current Ratio 4.88
Quick Ratio 4.88
BJDX Yearly Current Assets VS Current LiabilitesBJDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BJDX Growth Analysis

3.1 Past

  • BJDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.62%, which is quite impressive.
EPS 1Y (TTM)97.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.96%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year55.56%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BJDX Yearly Revenue VS EstimatesBJDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2025 2026 2M 4M 6M 8M
BJDX Yearly EPS VS EstimatesBJDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -5K -10K -15K

More info and screens

Find the best growth stocksShow best growing peers

0

4. BJDX Valuation Analysis

4.1 Price/Earnings Ratio

  • BJDX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BJDX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BJDX Price Earnings VS Forward Price EarningsBJDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BJDX Per share dataBJDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BJDX Dividend Analysis

5.1 Amount

  • No dividends for BJDX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BJDX Fundamentals: All Metrics, Ratios and Statistics

BLUEJAY DIAGNOSTICS INC

NASDAQ:BJDX (4/22/2026, 5:20:01 PM)

2

+0.08 (+4.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-28
Earnings (Next)N/A
Inst Owners4.07%
Inst Owner Change0%
Ins Owners2.38%
Ins Owner Change0%
Market Cap2.06M
Revenue(TTM)N/A
Net Income(TTM)-6.85M
Analysts43.33
Price TargetN/A
Short Float %4.38%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.34
EV/EBITDA N/A
EPS(TTM)-65.48
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-6.05
FCFYN/A
OCF(TTM)-5.88
OCFYN/A
SpS0
BVpS5.8
TBVpS5.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -96.2%
ROE -114.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-205.07%
ROA(5y)-140.12%
ROE(3y)-274.65%
ROE(5y)-184.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 234.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.88
Quick Ratio 4.88
Altman-Z -9.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)249.49%
Cap/Depr(5y)302.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.96%
EPS Next Y9.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year55.56%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.59%
OCF growth 3YN/A
OCF growth 5YN/A

BLUEJAY DIAGNOSTICS INC / BJDX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

ChartMill assigns a fundamental rating of 1 / 10 to BJDX.


What is the valuation status of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

ChartMill assigns a valuation rating of 0 / 10 to BLUEJAY DIAGNOSTICS INC (BJDX). This can be considered as Overvalued.


Can you provide the profitability details for BLUEJAY DIAGNOSTICS INC?

BLUEJAY DIAGNOSTICS INC (BJDX) has a profitability rating of 0 / 10.


What is the financial health of BLUEJAY DIAGNOSTICS INC (BJDX) stock?

The financial health rating of BLUEJAY DIAGNOSTICS INC (BJDX) is 4 / 10.


What is the expected EPS growth for BLUEJAY DIAGNOSTICS INC (BJDX) stock?

The Earnings per Share (EPS) of BLUEJAY DIAGNOSTICS INC (BJDX) is expected to grow by 9.38% in the next year.